Docusign (NASDAQ:DOCU) Reaches New 52-Week High – What’s Next?

Docusign Inc. (NASDAQ:DOCU) hit a new 52-week high during trading on Wednesday. The stock traded as high as $75.31 and last traded at $75.23, with a volume of 3,360,961 shares traded. The stock had previously closed at $72.31.

Key Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Expanded Salesforce integration is the primary catalyst. DocuSign’s Intelligent Agreement Management (IAM) platform will be embedded natively across Salesforce, Agentforce and Slack. The arrangement allows sales and revenue teams to manage agreements within their existing workflows and gives DocuSign access to Salesforce’s broad enterprise ecosystem. This could accelerate IAM adoption, improve customer engagement and support additional subscription revenue. DocuSign and Salesforce Launch Intelligent Agreement Management Natively Across Salesforce to Power Agentic Agreement Workflows
• Positive Sentiment: The partnership extends a relationship that has lasted more than 20 years and positions DocuSign to participate in Salesforce’s AI and agentic-workflow expansion. Investors may view the native integration as a stronger distribution channel for DocuSign’s AI-enabled products than standalone selling. Docusign embeds agreement platform directly into Salesforce
• Positive Sentiment: Zacks highlighted DOCU’s strong momentum, growing IAM adoption, AI-driven expansion and cash generation. The stock’s recent strength and trading near its 52-week high may be attracting momentum-focused investors. Here’s Why DocuSign Is a Strong Momentum Stock
• Neutral Sentiment: Market coverage noted that DOCU advanced even as the broader market weakened, reinforcing its current relative strength. However, the shares’ elevated valuation means investors may require evidence that the Salesforce agreement translates into faster growth.
• Negative Sentiment: Despite the constructive outlook, cloud-migration expenses and competition could pressure margins. Zacks therefore characterized DOCU as a stock to hold rather than an unqualified buy, leaving execution and profitability risks in focus. Here’s Why You Should Hold DOCU Stock in Your Portfolio Now

Analyst Upgrades and Downgrades

A number of analysts recently commented on DOCU shares. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a report on Friday, September 4th. Royal Bank Of Canada boosted their price target on Docusign from $55.00 to $70.00 and gave the stock a “sector perform” rating in a research note on Friday, September 4th. UBS Group raised their price objective on Docusign from $54.00 to $70.00 and gave the company a “neutral” rating in a research note on Friday, September 4th. BTIG Research raised their price objective on Docusign from $60.00 to $75.00 and gave the company a “buy” rating in a research note on Wednesday, September 2nd. Finally, Weiss Ratings upgraded Docusign from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $67.33.

Docusign Stock Performance

The company has a market capitalization of $14.06 billion, a price-to-earnings ratio of 45.87, a P/E/G ratio of 2.63 and a beta of 0.86. The company has a fifty day simple moving average of $65.60 and a two-hundred day simple moving average of $54.15.

Docusign (NASDAQ:DOCU) last released its earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. The firm had revenue of $875.75 million during the quarter, compared to the consensus estimate of $867.22 million. Docusign had a net margin of 9.82% and a return on equity of 18.29%. Docusign’s revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.30 earnings per share. As a group, analysts expect that Docusign Inc. will post 2.13 EPS for the current year.

Insider Buying and Selling at Docusign

In related news, Director Mary Wilderotter sold 1,000 shares of Docusign stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $68.80, for a total transaction of $68,800.00. Following the sale, the director owned 2,199 shares of the company’s stock, valued at $151,291.20. The trade was a 31.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 3,300 shares of the business’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $68.81, for a total transaction of $227,073.00. Following the completion of the transaction, the executive owned 106,557 shares in the company, valued at $7,332,187.17. This represents a 3.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 165,868 shares of company stock worth $11,121,890. Insiders own 0.59% of the company’s stock.

Hedge Funds Weigh In On Docusign

A number of institutional investors have recently made changes to their positions in DOCU. Tred Avon Family Wealth LLC lifted its holdings in shares of Docusign by 3.6% in the first quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock valued at $293,000 after purchasing an additional 215 shares in the last quarter. Riversedge Advisors LLC lifted its position in shares of Docusign by 4.5% during the third quarter. Riversedge Advisors LLC now owns 5,182 shares of the company’s stock valued at $348,000 after purchasing an additional 225 shares in the last quarter. First Citizens Bank & Trust Co. grew its position in Docusign by 2.1% in the 1st quarter. First Citizens Bank & Trust Co. now owns 11,745 shares of the company’s stock worth $557,000 after purchasing an additional 239 shares in the last quarter. Integrated Wealth Concepts LLC grew its holdings in shares of Docusign by 2.0% in the second quarter. Integrated Wealth Concepts LLC now owns 14,359 shares of the company’s stock valued at $638,000 after acquiring an additional 277 shares in the last quarter. Finally, OMERS ADMINISTRATION Corp grew its stake in Docusign by 3.4% in the 1st quarter. OMERS ADMINISTRATION Corp now owns 8,878 shares of the company’s stock valued at $421,000 after purchasing an additional 296 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Docusign Company Profile

DocuSign, Inc (NASDAQ:DOCU) provides cloud-based software for electronically signing, managing and automating agreements. Its platform enables individuals and organizations to prepare, send, sign, track and store documents digitally, helping replace paper-based contracting processes.

The company’s offerings include electronic signature tools, contract lifecycle management, identity verification and authentication services, document generation, agreement analytics and related workflow automation capabilities.